|
Sign In to gain access to subscriptions and/or personal tools.
|
Transforming Growth Factor-ß and Wound Healing
Byron J. Faler, MD
Departments of Surgery, Veterans Affairs Medical Center, Walter Reed Army Medical Center; Washington, DC
Robyn A. Macsata, MD
Dahlia Plummer, MD
Departments of Surgery, Veterans Affairs Medical Center; Washington, DC
Lopa Mishra, MD
Departments of Surgery, Veterans Affairs Medical Center, Georgetown University Medical Center; Washington, DC
Anton N. Sidawy, MD
Departments of Surgery, Veterans Affairs Medical Center, Georgetown University Medical Center, George Washington University Medical Center; Washington, DC
Acute and chronic wounds are a source of significant morbidity for patients, and they demand a growing portion of health-care time and finances to be devoted to their care. Transforming growth factor-ß (TGF-ß) has surfaced from abundant research as a key signal in orchestrating wound repair. In beginning this review, we discuss the inflammatory, proliferative, and maturational phases of wound healing. We then focus on TGF-ß by first discussing the pathway from its production to the target cell where Smad proteins execute an intracellular signaling cascade. To review TGF-ß's role in wound healing, we discuss the actions of it individually on keratinocytes, fibroblasts, endothelial cells, and monocytes, which are the major cell types involved in wound repair. From illustrating these cellular actions of TGF-ß, we summarize its multipotent role in the process of wound repair. As a clinical correlation, we also review research dedicated to the involvement of TGF-ß in venous stasis ulcers.
Key Words: transforming growth factor-beta Smad proteins wound healing venous stasis ulcer
References
- 1. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 46:381-386, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 2. Cross KJ, Mustoe TA. Growth factors in wound healing. Surg Clin North Am 83:531-545, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 3. Sidawy AN. Peptide growth factors and their role in the proliferative diseases of the vascular system. In Sidawy AN, Sumpio BE, DePalma RG, editors: The Basic Science of Vascular Disease. Armonk, NY: Futura Publishing Company, Inc; 1997. pp 127-149.
- 4. Rothe M, Falanga V. Growth factors. Their biology and promise in dermatologic diseases and tissue repair. Arch Dermatol 125:1390-1398, 1989.[Abstract/Free Full Text]
- 5. Cross KJ, Mustoe TA. Growth factors in wound healing. Surg Clin North Am 83:531-545, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 6. DeLarco JE, Todaro GJ. Growth factors from murine-sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75:4001-4005, 1978.[Abstract/Free Full Text]
- 7. Madisen L, Lioubin MN, Farrand AL, et al. Analysis of proteolytic cleavage of recombinant TGF-ß1: production of hybrid molecules with increased processing efficiency. Ann NY Acad Sci 593:7-25, 1990.[Web of Science][Medline]
[Order article via Infotrieve]
- 8. Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 35:83-92, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 9. Roberts AB, Piek E, Bottinger EP, et al Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest 120:43S-47S, 2001.[Medline]
[Order article via Infotrieve]
- 10. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85:47-64, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 11. Verrecchia F, Mauviel A. TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal 16:873-880, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 12. Ghosh AK, Yuan W, Mori Y, et al. Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 276:11041-11408, 2001.[Abstract/Free Full Text]
- 13. Tang Y, Katuri V, Dillner A, et al. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science 299:574-577, 2003.[Abstract/Free Full Text]
- 14. Ashcroft GS, Roberts AB. Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 11:125-131, 2000.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 15. Ashcroft G, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and impaired local inflammatory response. Nature Cell Biology 1:260-266, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 16. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987.[Web of Science][Medline]
[Order article via Infotrieve]
- 17. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103: 2403-2410, 1986.[Abstract/Free Full Text]
- 18. Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 262:17467-17474, 1987.[Abstract/Free Full Text]
- 19. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986.[Abstract/Free Full Text]
- 20. Muller G, Behrens J, Nussbaumer U, Bohlen P, Birchmeier W. Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci USA 84:5600-5604, 1987.[Abstract/Free Full Text]
- 21. Collo G, Pepper MS. Endothelial cell integrin a5p1 expression is modulated by cytokines and during migration in vitro. J Cell Science 112 (Pt 4):569-578, 1999.[Abstract]
- 22. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43, 1997.[CrossRef][Medline]
[Order article via Infotrieve]
- 23. Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK) 1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12:817-828, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 24. Lal BK, Saito S, Pappas PJ, et al. Altered proliferative responses of dermal fibroblasts to TGF-betal may contribute to chronic venous stasis ulcer J Vasc Surg 37:1285-1293, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 25. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 84:640-646, 1989.[Web of Science][Medline]
[Order article via Infotrieve]
- 26. Schultze-Mosgau S, Blaese MA, Grabenbauer G, et al. Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbetal)-treatment in irradiated rat tissue. Radiother Oncol 70:249-259, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 27. Dhainaut JF, Charpentier J, Chiche JD. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 31:S258-S264, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 28. Narine K, DeWever O, Cathenis K, et al. Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering. J Heart Valve Dis 13:281-289, 2004.[Web of Science][Medline]
[Order article via Infotrieve]
- 29. Shephard P, Hinz B, Smola-Hess S, et al. Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes. Thromb Haemost 92:262-274, 2004.[Web of Science][Medline]
[Order article via Infotrieve]
- 30. Cucoranu I, Clempus R, Dikalova A, et al. NAD(P)H oxidase 4 mediates transforming growth factor betal induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97:900-907, 2005.[Abstract/Free Full Text]
- 31. Shephard P, Martin G, Smola-Hess S, et al. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol 164:2055-2066, 2004.[Abstract/Free Full Text]
- 32. Hu B, Wu Z, Phan SH. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol 29:397-404, 2003.[Abstract/Free Full Text]
- 33. Mustoe TA, Pierce GF, Thomason A, et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237:1333-1336, 1987.[Abstract/Free Full Text]
- 34. Badiavas EV, Zhou L, Falanga V. Growth inhibition of primary keratinocytes following transduction with a novel TGFbeta-1 containing retrovirus. J Dermatol Sci 27:1-6, 2001.[Web of Science][Medline]
[Order article via Infotrieve]
- 35. Jeong HW, Kim IS. TGF-betal enhances betaig-h3-mediated keratinocyte cell migration through the alpha3beta1 integrin and P13K. J Cell Biochem 92:770-780, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 36. Lu L, Saulis AS, Liu WR, et al. The temporal effects of anti-TGF-betal, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201:391-397, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 37. Tredget EB, Demare J, Chandran G, et al. Transforming growth factor-beta and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen 13:61-67, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 38. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol 132:79-85, 1995.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 39. Falanga V, Eaglstein WH. The "trap" hypothesis of venous ulceration. Lancet 341:1006-1008, 1993.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 40. Stacey MC, Burnand KG, Bhogal BS, Black MM. Pericapillary fibrin deposits and skin hypoxia precede the changes of lipodermatosclerosis in limbs at increased risk of developing a venous ulcer. Cardiovasc Surg 8:372-380, 2000.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 41. Falanga V, Kirsner R, Katz MH, et al. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing. J Dermatol Surg Oncol 18:409-414, 1992.[Web of Science][Medline]
[Order article via Infotrieve]
- 42. Hasan A, Murata H, Falabella A, et al. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci 16:59-66, 1997.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 43. Kim BC, Kim HT, Park SH, et al. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol 195:331-336, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 44. Cowin AJ, Hatzirodos N, Holding CA, et al. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers. J Invest Dermatol 117:1282-1289, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 18, No. 1,
55-62 (2006)
DOI: 10.1177/153100350601800123

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Bu, B. Kapanadze, T. Hsu, and M. Trojanowska
Opposite Effects of Dihydrosphingosine 1-Phosphate and Sphingosine 1-Phosphate on Transforming Growth Factor-{beta}/Smad Signaling Are Mediated through the PTEN/PPM1A-dependent Pathway
J. Biol. Chem.,
July 11, 2008;
283(28):
19593 - 19602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Reitzel, J. C. Sullivan, N. Traylor-knowles, and J. R. Finnerty
Genomic Survey of Candidate Stress-Response Genes in the Estuarine Anemone Nematostella vectensis
Biol. Bull.,
June 1, 2008;
214(3):
233 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Semlali, E. Jacques, S. Plante, S. Biardel, J. Milot, M. Laviolette, L.-P. Boulet, and J. Chakir
TGF- Suppresses EGF-Induced MAPK Signaling and Proliferation in Asthmatic Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
February 1, 2008;
38(2):
202 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Sze, D. P. V. de Kleijn, R. C. Lai, E. Khia Way Tan, H. Zhao, K. S. Yeo, T. Y. Low, Q. Lian, C. N. Lee, W. Mitchell, et al.
Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells
Mol. Cell. Proteomics,
October 1, 2007;
6(10):
1680 - 1689.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|